| Year |
Citation |
Score |
| 2011 |
Soignier RD, Taylor BK, Baiamonte BA, Lee FA, Paul D, Gould HJ. Measurement of CFA-induced hyperalgesia and morphine-induced analgesia in rats: dorsal vs plantar mechanical stimulation of the hindpaw. Pain Medicine (Malden, Mass.). 12: 451-8. PMID 21332938 DOI: 10.1111/j.1526-4637.2011.01066.x |
0.405 |
|
| 2000 |
Ware TD, Paul D. Cross-tolerance between analgesia produced by xylazine and selective opioid receptor subtype treatments European Journal of Pharmacology. 389: 181-185. PMID 10688982 DOI: 10.1016/S0014-2999(99)00900-0 |
0.464 |
|
| 1997 |
Paul D, Gauthier CA, Minor LD, Gonzales GR. The effects of postmortem delay on mu, delta and kappa opioid receptor subtypes in rat brain and guinea pig cerebellum evaluated by radioligand receptor binding Life Sciences. 61: 1993-1998. PMID 9366506 DOI: 10.1016/S0024-3205(97)00857-6 |
0.413 |
|
| 1997 |
Paul D, Fowler A, Ware TD, Gergen KA. Selective Norepinephrine and 5-Hydroxytryptamine Transport Blockade Effects on Analgesia Produced by Stimulation of Opioid Receptor Subtypes Analgesia. 3: 43-49. DOI: 10.3727/107156997819566109 |
0.42 |
|
| 1996 |
Gergen KA, Zadina JE, Paul D. Analgesic effects of Tyr-W-MIF-1: a mixed mu2-opioid receptor agonist/mu1-opioid receptor antagonist. European Journal of Pharmacology. 316: 33-8. PMID 8982647 DOI: 10.1016/S0014-2999(96)00656-5 |
0.515 |
|
| 1996 |
Zadina JE, Paul D, Gergen KA, Ge LJ, Hackler L, Kastin AJ. Binding of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2) and related peptides to mu 1 and mu 2 opiate receptors. Neuroscience Letters. 215: 65-9. PMID 8880755 DOI: 10.1016/S0304-3940(96)12928-1 |
0.387 |
|
| 1996 |
Gergen KA, Zadina JE, Kastin AJ, Paul D. Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha 2-adrenoceptors. European Journal of Pharmacology. 298: 235-9. PMID 8846821 DOI: 10.1016/0014-2999(95)00823-3 |
0.504 |
|
| 1995 |
Paul D, Tran JG. Differential cross-tolerance between analgesia produced by α2-adrenoceptor agonists and receptor subtype selective opioid treatments European Journal of Pharmacology. 272: 111-114. PMID 7713142 DOI: 10.1016/0014-2999(94)00695-4 |
0.463 |
|
| 1995 |
Mosaddeghi M, Kapusta DR, Minor LD, Duan N, Paul D. Effects of κ-opioid receptor agonists on stimulated phosphoinositide hydrolysis in rat kidney European Journal of Pharmacology: Molecular Pharmacology. 289: 411-417. PMID 7556409 DOI: 10.1016/0922-4106(95)90149-3 |
0.382 |
|
| 1994 |
Paul D, Hornby PJ. Potentiation of intrathecal DAMGO antinociception, but not gastrointestinal transit inhibition, by 5-hydroxytryptamine and norepinephrine uptake blockade Life Sciences. 56: PL83-PL87. PMID 7823777 DOI: 10.1016/0024-3205(94)00924-4 |
0.362 |
|
| 1993 |
Carr DJJ, Gebhardt BM, Paul D. Alpha adrenergic and mu-2 opioid receptors are involved in morphine- induced suppression of splenocyte natural killer activity Journal of Pharmacology and Experimental Therapeutics. 264: 1179-1186. PMID 8383741 |
0.514 |
|
| 1992 |
Roane DS, Paul D. Evidence of hyperglycemic hyperalgesia by quinpirole. Pharmacology, Biochemistry, and Behavior. 41: 65-7. PMID 1347178 DOI: 10.1016/0091-3057(92)90060-S |
0.477 |
|
| 1992 |
Tive LA, Pick CG, Paul D, Roques BP, Gacel GA, Pasternak GW. Analgesic potency of TRIMU-5: a mixed mu 2 opioid receptor agonist/mu 1 opioid receptor antagonist. European Journal of Pharmacology. 216: 249-55. PMID 1327812 DOI: 10.1016/0014-2999(92)90367-D |
0.692 |
|
| 1992 |
Pick CG, Paul D, Pasternak GW. Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice. The Journal of Pharmacology and Experimental Therapeutics. 262: 1044-50. PMID 1326621 |
0.663 |
|
| 1992 |
Pick CG, Paul D, Eison MS, Pasternak GW. Potentiation of opioid analgesia by the antidepressant nefazodone. European Journal of Pharmacology. 211: 375-81. PMID 1319913 DOI: 10.1016/0014-2999(92)90395-K |
0.67 |
|
| 1991 |
Pick CG, Paul D, Pasternak GW. Comparison of naloxonazine and beta-funaltrexamine antagonism of mu 1 and mu 2 opioid actions. Life Sciences. 48: 2005-11. PMID 1851915 DOI: 10.1016/0024-3205(91)90155-5 |
0.597 |
|
| 1991 |
Paul D, Pick CG, Tive LA, Pasternak GW. Pharmacological characterization of nalorphine, a kappa 3 analgesic. The Journal of Pharmacology and Experimental Therapeutics. 257: 1-7. PMID 1850462 |
0.663 |
|
| 1991 |
Kepler KL, Standifer KM, Paul D, Kest B, Pasternak GW, Bodnar RJ. Gender effects and central opioid analgesia. Pain. 45: 87-94. PMID 1677751 DOI: 10.1016/0304-3959(91)90168-W |
0.669 |
|
| 1991 |
Pick CG, Cheng J, Paul D, Pasternak GW. Genetic influences in opioid analgesic sensitivity in mice. Brain Research. 566: 295-8. PMID 1667610 DOI: 10.1016/0006-8993(91)91712-A |
0.611 |
|
| 1991 |
Bodnar R, Paul D, Pasternak GW. Synergistic analgesic interactions between the periaqueductal gray and the locus coeruleus. Brain Research. 558: 224-30. PMID 1664270 DOI: 10.1016/0006-8993(91)90772-N |
0.647 |
|
| 1990 |
Paul D, Pinel JP. Pirenperone does not attenuate morphine analgesia in spinal rats. Psychopharmacology. 100: 98-101. PMID 2296631 DOI: 10.1007/BF02245797 |
0.668 |
|
| 1990 |
Bodnar RJ, Paul D, Rosenblum M, Liu L, Pasternak GW. Blockade of morphine analgesia by both pertussis and cholera toxins in the periaqueductal gray and locus coeruleus. Brain Research. 529: 324-8. PMID 2282501 DOI: 10.1016/0006-8993(90)90845-3 |
0.656 |
|
| 1990 |
Paul D, Levison JA, Howard DH, Pick CG, Hahn EF, Pasternak GW. Naloxone benzoylhydrazone (NalBzoH) analgesia. The Journal of Pharmacology and Experimental Therapeutics. 255: 769-74. PMID 2173757 |
0.664 |
|
| 1990 |
Bodnar RJ, Paul D, Pasternak GW. Proglumide selectively potentiates supraspinal mu 1 opioid analgesia in mice. Neuropharmacology. 29: 507-10. PMID 2162497 DOI: 10.1016/0028-3908(90)90174-P |
0.709 |
|
| 1990 |
Paul D, Phillips AG. Associative factors in tolerance to analgesia produced by electrical stimulation in the brainstem. Behavioral Neuroscience. 104: 207-16. PMID 2156521 DOI: 10.1037/h0092462 |
0.42 |
|
| 1990 |
Standifer KM, Paul D, Howard D, Levison J, Pasternak GW. Differential effects of dexamethasone on opioid receptor-mediated analgesia and selective binding New Leads in Opioid Research: Proceedings of the International Narcotics Research Conference. Ics914. 31-32. |
0.44 |
|
| 1990 |
Tive LA, Paul D, Liu L, Pasternak GW. Partial agonist effects of ethylketocyclazocine at supraspinal mu1 receptors New Leads in Opioid Research: Proceedings of the International Narcotics Research Conference. Ics914. 57-58. |
0.386 |
|
| 1990 |
Paul D, Pick CG, Pasternak GW. Dissociation of kappa1 and kappa3 analgesia: Pharmacological characterization of naloxone benzoylhydrazine New Leads in Opioid Research: Proceedings of the International Narcotics Research Conference. Ics914. 56. |
0.487 |
|
| 1989 |
Paul D, Standifer KM, Inturrisi CE, Pasternak GW. Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite. The Journal of Pharmacology and Experimental Therapeutics. 251: 477-83. PMID 2810109 |
0.647 |
|
| 1989 |
Bodnar RJ, Pasternak GW, Mann PE, Paul D, Warren R, Donner DB. Mediation of anorexia by human recombinant tumor necrosis factor through a peripheral action in the rat. Cancer Research. 49: 6280-4. PMID 2804974 |
0.433 |
|
| 1989 |
Kiefel JM, Paul D, Bodnar RJ. Reduction in opioid and non-opioid forms of swim analgesia by 5-HT2 receptor antagonists. Brain Research. 500: 231-40. PMID 2605492 DOI: 10.1016/0006-8993(89)90318-1 |
0.493 |
|
| 1989 |
Ling GS, Paul D, Simantov R, Pasternak GW. Differential development of acute tolerance to analgesia, respiratory depression, gastrointestinal transit and hormone release in a morphine infusion model. Life Sciences. 45: 1627-36. PMID 2555641 DOI: 10.1016/0024-3205(89)90272-5 |
0.604 |
|
| 1989 |
Paul D, Bodnar RJ, Gistrak MA, Pasternak GW. Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice. European Journal of Pharmacology. 168: 307-14. PMID 2555205 DOI: 10.1016/0014-2999(89)90792-9 |
0.638 |
|
| 1989 |
Gistrak MA, Paul D, Hahn EF, Pasternak GW. Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone. The Journal of Pharmacology and Experimental Therapeutics. 251: 469-76. PMID 2553921 |
0.674 |
|
| 1989 |
Yoburn BC, Paul D, Azimuddin S, Lutfy K, Sierra V. Chronic opioid antagonist treatment increases μ and δ receptor mediated spinal cord opioid analgesia Brain Research. 485: 176-178. PMID 2541864 DOI: 10.1016/0006-8993(89)90680-X |
0.55 |
|
| 1988 |
Paul D, Mana MJ, Pfaus JG, Pinel JP. Attenuation of morphine analgesia by the S2 antagonists, pirenperone and ketanserin. Pharmacology, Biochemistry, and Behavior. 31: 641-7. PMID 3251248 DOI: 10.1016/0091-3057(88)90243-2 |
0.736 |
|
| 1988 |
Paul D, Pasternak GW. Differential blockade by naloxonazine of two mu opiate actions: analgesia and inhibition of gastrointestinal transit. European Journal of Pharmacology. 149: 403-4. PMID 2842168 DOI: 10.1016/0014-2999(88)90680-2 |
0.574 |
|
| 1988 |
Jacobs WJ, Blackburn JR, Buttrick M, Harpur TJ, Kennedy D, Mana MJ, MacDonald MA, McPherson LM, Paul D, Pfaus JG. Observations Psychobiology. 16: 3-19. DOI: 10.3758/BF03327295 |
0.413 |
|
| 1986 |
Paul D, Phillips AG. Selective effects of pirenperone on analgesia produced by morphine or electrical stimulation at sites in the nucleus raphe magnus and periaqueductal gray. Psychopharmacology. 88: 172-6. PMID 3081929 DOI: 10.1007/BF00652235 |
0.582 |
|
| Show low-probability matches. |